BI 905677

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 905677, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) [Phase 1]

See pricing